BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15136764)

  • 21. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Ampullary Adenocarcinoma].
    Shin DW
    Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
    Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
    Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
    Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection.
    Ehehalt F; Rümmele P; Kersting S; Lang-Schwarz C; Rückert F; Hartmann A; Dietmaier W; Terracciano L; Aust DE; Jahnke B; Saeger HD; Pilarsky C; Grützmann R
    Ann Surg; 2011 Aug; 254(2):302-10. PubMed ID: 21494118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucins differently expressed in various ampullary adenocarcinomas.
    Wang T; Liang YM; Hu P; Cheng YF
    Diagn Pathol; 2011 Oct; 6():102. PubMed ID: 22027009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer.
    Bloomston M; Ellison EC; Muscarella P; Al-Saif O; Martin EW; Melvin WS; Frankel WL
    Ann Surg Oncol; 2007 Jan; 14(1):211-7. PubMed ID: 17080236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.
    Koopmann J; Fedarko NS; Jain A; Maitra A; Iacobuzio-Donahue C; Rahman A; Hruban RH; Yeo CJ; Goggins M
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):487-91. PubMed ID: 15006928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma.
    Sandhu V; Bowitz Lothe IM; Labori KJ; Skrede ML; Hamfjord J; Dalsgaard AM; Buanes T; Dube G; Kale MM; Sawant S; Kulkarni-Kale U; Børresen-Dale AL; Lingjærde OC; Kure EH
    Mol Oncol; 2016 Feb; 10(2):303-16. PubMed ID: 26590090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
    Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
    J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
    Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological identification of ampullary adenocarcinomas.
    Relias V; Saif MW
    JOP; 2014 Jul; 15(4):306-7. PubMed ID: 25076327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
    Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
    BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of tumor proliferative indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays.
    Aloysius MM; Hewavisenthi SJ; Bates TE; Rowlands BJ; Lobo DN; Zaitoun AM
    World J Surg; 2010 Sep; 34(9):2115-21. PubMed ID: 20556608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Kang SP; Saif MW
    JOP; 2011 Mar; 12(2):123-5. PubMed ID: 21386636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
    Chiorean EG; Chiaro MD; Tempero MA; Malafa MP; Benson AB; Cardin DB; Christensen JA; Chung V; Czito B; Dillhoff M; Donahue TR; Dotan E; Fountzilas C; Glazer ES; Hardacre J; Hawkins WG; Klute K; Ko AH; Kunstman JW; LoConte N; Lowy AM; Masood A; Moravek C; Nakakura EK; Narang AK; Nardo L; Obando J; Polanco PM; Reddy S; Reyngold M; Scaife C; Shen J; Truty MJ; Vollmer C; Wolff RA; Wolpin BM; Rn BM; Lubin S; Darlow SD
    J Natl Compr Canc Netw; 2023 Jul; 21(7):753-782. PubMed ID: 37433437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the investigation and surgical management of resectable ampullary adenocarcinoma.
    Askew J; Connor S
    HPB (Oxford); 2013 Nov; 15(11):829-38. PubMed ID: 23458317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.
    Sandhu V; Bowitz Lothe IM; Labori KJ; Lingjærde OC; Buanes T; Dalsgaard AM; Skrede ML; Hamfjord J; Haaland T; Eide TJ; Børresen-Dale AL; Ikdahl T; Kure EH
    Mol Oncol; 2015 Apr; 9(4):758-71. PubMed ID: 25579086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local ampullary resection with careful intraoperative frozen section evaluation for presumed benign ampullary neoplasms.
    Clary BM; Tyler DS; Dematos P; Gottfried M; Pappas TN
    Surgery; 2000 Jun; 127(6):628-33. PubMed ID: 10840357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.